Ulcerative colitis: sclerosing cholangitis today, cancer tomorrow? by Broomé, U, Chapman, R

DETECTION OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODY IN PRIMARY SCLEROSING CHOLANGITIS - COMPARISON OF THE ALKALINE-PHOSPHATASE AND IMMUNOFLUORESCENT TECHNIQUES by Bansi, D, Boberg, K, Broome, U, Chapman, R, Fleming, K, Jorgensen, R, Lindor, K, Schrumpf, E

Detection of antineutrophil cytoplasmic antibody in primary sclerosing cholangitis: Comparison of the alkaline phosphatase and immunofluorescent techniques. by Bansi, D, Boberg, K, Broome, U, Chapman, R, Fleming, K, Jorgensen, R, Lindor, K, Schrumpf, E

Prognostic indicators of primary sclerosing cholangitis determined by a cox phase-specific time-dependent model. by Boberg, K, Rocca, G, Spurkland, A, Broome, U, Chapman, R, Mitchell, S, Pares, A, Rosina, F, Schrumpf, E

HLA class II haplotypes in primary sclerosing cholangitis patients from five ethnic groups. by Saarinen, S, Boberg, K, Spurkland, A, Mitchell, S, Broome, U, Rosina, F, Chapman, R, Pares, A, Olerup, O, Schrumpf, E

Natural history of primary sclerosing cholangitis. A longterm follow-up study of 394 European primary sclerosing cholangitis patients by Boberg, K, Mitchell, S, Broome, U, Pares, A, Rosina, F, Bergquist, A, Chapman, R, Fause, O, Rocca, G, Schrumpf, E

Cholangiocarcinoma in primary sclerosing cholangitis is associated with long-standing inflammatory bowel disease. A long-term follow-up of 394 primary sclerosing cholangitis patien... by Boberg, K, Bergquist, A, Mitchell, S, Pares, A, Rosina, F, Broome, U, Chapman, R, Fausa, O, Rocca, G, Schrumpf, E

Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation. by Boberg, K, Bergquist, A, Mitchell, S, Pares, A, Rosina, F, Broomé, U, Chapman, R, Fausa, O, Egeland, T, Rocca, G, Schrumpf, E

The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis. by Boberg, K, Spurkland, A, Rocca, G, Egeland, T, Saarinen, S, Mitchell, S, Broomé, U, Chapman, R, Olerup, O, Pares, A, Rosina, F, Schrumpf, E

Detection of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: a comparison of the alkaline phosphatase and immunofluorescent techniques. by Bansi, D, Bauducci, M, Bergqvist, A, Boberg, K, Broome, U, Chapman, R, Fleming, K, Jorgensen, R, Lindor, K, Rosina, F, Schrumpf, E

New time dependent prognostic models for primary sclerosing cholangitis (PSC) by Rocca, G, Boberg, K, Egeland, T, Bergquist, A, Broome, U, Caballeria, L, Chapman, R, Hultcrantz, R, Mitchell, S, Pares, A, Rosina, F, Schrumpf, E

Time-dependent Cox regression model is superior in prediction of prognosis in primary sclerosing cholangitis. by Boberg, K, Rocca, G, Egeland, T, Bergquist, A, Broomé, U, Caballeria, L, Chapman, R, Hultcrantz, R, Mitchell, S, Pares, A, Rosina, F, Schrumpf, E

Inability to attribute susceptibility to primary sclerosing cholangitis to specific amino acid positions of the HLA-DRw52a allele. by Olerup, O, Broome, U, Einarsson, K, Zetterquist, H, Mehal, W, Wordsworth, B, Taylor, C, Bell, J, Fleming, K, Chapman, R, Min, S, Terasaki, P

HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. by Spurkland, A, Saarinen, S, Boberg, K, Mitchell, S, Broome, U, Caballeria, L, Ciusani, E, Chapman, R, Ercilla, G, Fausa, O, Knutsen, I, Pares, A, Rosina, F, Olerup, O, Thorsby, E, Schrumpf, E